Private · Company · Aksjeselskap
Glaxosmithkline AS
↳ Brreg · companies
MoneyNOK
Revenue
kr 1.26bn
Operating result
kr 38M
Net result
kr 29.1M
Total assets
kr 421.5M
Equity
kr 118.1M
FY2025 kr 1.26bn vs FY2024 kr 1.04bn · +22% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
- Revenue
- Net profit
| FY24 | FY25 | |
|---|---|---|
| Revenue | 1.04bn | 1.26bn |
| Net profit | 26.2M | 29.1M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY24FY25TREND
Revenue1039M1264M
Operating result33M38M
Net result26M29M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by DELOITTE AS.
BALANCEEquity kr 118.1M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose